TickerFacts.

Absci Corp (ABSI): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$92.92M
Year ended 2025-12-31
-$108.08M
Trailing 12 months to 2026-06-30
2020-12-31: -$10.97M2021-12-31: -$60.60M2022-12-31: -$81.34M2023-12-31: -$64.64M2024-12-31: -$72.40M2025-12-31: -$92.92M-$92.92M
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$92.92Mn/m2026-03-24, From 2025-01-01
2024-12-31-$72.40Mn/m2026-03-24, From 2024-01-01
2023-12-31-$64.64Mn/m2025-03-18, From 2023-01-01
2022-12-31-$81.34Mn/m2024-03-21, From 2022-01-01
2021-12-31-$60.60Mn/m2023-03-30, From 2021-01-01
2020-12-31-$10.97Mn/a2022-03-22, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Absci Corp (ABSI)2025-12-31-$92.92Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$4.24Mn/m
OneMedNet Corp (ONMD)2025-12-31-$7.50Mn/m
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$9.33Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$3.87Mn/m
OmniAb, Inc. (OABI)2025-12-31-$36.45Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$329.6Kn/m
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
NRC Health (NRC)2025-12-31$26.45M-23.6%

Compare ABSI, ISPC, ONMD, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗